(CMP) Compass Minerals - Overview
Sector: Basic MaterialsIndustry: Other Industrial Metals & Mining | Exchange NYSE (USA) | Currency USD | Market Cap: 997m | Total Return 142.4% in 12m
Stock: Salt, Fertilizers, Chemicals
Total Rating 62
Risk 77
Buy Signal -0.37
| Risk 5d forecast | |
|---|---|
| Volatility | 57.2% |
| Relative Tail Risk | -9.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.83 |
| Alpha | 123.62 |
| Character TTM | |
|---|---|
| Beta | 1.228 |
| Beta Downside | 1.114 |
| Drawdowns 3y | |
|---|---|
| Max DD | 79.73% |
| CAGR/Max DD | -0.15 |
EPS (Earnings per Share)
Revenue
Description: CMP Compass Minerals March 06, 2026
Compass Minerals International Inc. (CMP) is a US-based company operating in the diversified metals and mining sector. It provides essential minerals across North America and internationally.
The company operates through two segments: Salt and Plant Nutrition. The Salt segment produces and sells various sodium and magnesium chloride products. These products are primarily used for de-icing roadways, a critical function in regions with cold climates, and for industrial applications like chemical production and water treatment. The Plant Nutrition segment focuses on sulfate of potash specialty fertilizers, sold under the Protassium+ brand. These fertilizers are vital for agricultural productivity, supplying essential nutrients to crops.
For more detailed financial analysis and performance metrics, consider exploring ValueRay.
Headlines to watch out for
- Winter weather severity impacts de-icing salt demand
- Agricultural commodity prices influence fertilizer sales
- Energy costs affect production and transportation expenses
- Regulatory changes impact environmental compliance costs
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -37.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 7.60 > 1.0 |
| NWC/Revenue: 29.15% < 20% (prev 37.20%; Δ -8.05% < -1%) |
| CFO/TA 0.11 > 3% & CFO 164.8m > Net Income -37.6m |
| Net Debt (850.2m) to EBITDA (149.1m): 5.70 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.3m) vs 12m ago 1.99% < -2% |
| Gross Margin: 16.48% > 18% (prev 0.15%; Δ 1.63k% > 0.5%) |
| Asset Turnover: 82.08% > 50% (prev 62.93%; Δ 19.15% > 0%) |
| Interest Coverage Ratio: 0.66 > 6 (EBITDA TTM 149.1m / Interest Expense TTM 69.7m) |
Altman Z'' 1.60
| A: 0.25 (Total Current Assets 632.2m - Total Current Liabilities 243.7m) / Total Assets 1.53b |
| B: -0.04 (Retained Earnings -59.0m / Total Assets 1.53b) |
| C: 0.03 (EBIT TTM 46.3m / Avg Total Assets 1.62b) |
| D: -0.13 (Book Value of Equity -159.8m / Total Liabilities 1.27b) |
| Altman-Z'' Score: 1.60 = BB |
Beneish M -3.45
| DSRI: 0.86 (Receivables 278.6m/261.7m, Revenue 1.33b/1.08b) |
| GMI: 0.89 (GM 16.48% / 14.61%) |
| AQI: 0.59 (AQ_t 0.08 / AQ_t-1 0.14) |
| SGI: 1.23 (Revenue 1.33b / 1.08b) |
| TATA: -0.13 (NI -37.6m - CFO 164.8m) / TA 1.53b) |
| Beneish M-Score: -3.45 (Cap -4..+1) = AA |
What is the price of CMP shares?
As of March 29, 2026, the stock is trading at USD 23.05 with a total of 350,317 shares traded.
Over the past week, the price has changed by +7.21%, over one month by -8.53%, over three months by +17.90% and over the past year by +142.38%.
Over the past week, the price has changed by +7.21%, over one month by -8.53%, over three months by +17.90% and over the past year by +142.38%.
Is CMP a buy, sell or hold?
Compass Minerals has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy CMP.
- StrongBuy: 1
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CMP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 25.8 | 11.7% |
| Analysts Target Price | 25.8 | 11.7% |
CMP Fundamental Data Overview March 28, 2026
P/E Forward = 12.7226
P/S = 0.6585
P/B = 3.4551
P/EG = 0.1192
Revenue TTM = 1.33b USD
EBIT TTM = 46.3m USD
EBITDA TTM = 149.1m USD
Long Term Debt = 883.6m USD (from longTermDebt, last quarter)
Short Term Debt = 6.90m USD (from shortTermDebt, last quarter)
Debt = 896.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 850.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.85b USD (997.2m + Debt 896.9m - CCE 46.7m)
Interest Coverage Ratio = 0.66 (Ebit TTM 46.3m / Interest Expense TTM 69.7m)
EV/FCF = 19.63x (Enterprise Value 1.85b / FCF TTM 94.1m)
FCF Yield = 5.09% (FCF TTM 94.1m / Enterprise Value 1.85b)
FCF Margin = 7.06% (FCF TTM 94.1m / Revenue TTM 1.33b)
Net Margin = -2.82% (Net Income TTM -37.6m / Revenue TTM 1.33b)
Gross Margin = 16.48% ((Revenue TTM 1.33b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 15.96% (prev 16.88%)
Tobins Q-Ratio = 1.21 (Enterprise Value 1.85b / Total Assets 1.53b)
Interest Expense / Debt = 2.02% (Interest Expense 18.1m / Debt 896.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 36.6m (EBIT 46.3m * (1 - 21.00%))
Current Ratio = 2.59 (Total Current Assets 632.2m / Total Current Liabilities 243.7m)
Debt / Equity = 3.44 (Debt 896.9m / totalStockholderEquity, last quarter 260.5m)
Debt / EBITDA = 5.70 (Net Debt 850.2m / EBITDA 149.1m)
Debt / FCF = 9.04 (Net Debt 850.2m / FCF TTM 94.1m)
Total Stockholder Equity = 245.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.32% (Net Income -37.6m / Total Assets 1.53b)
RoE = -15.33% (Net Income TTM -37.6m / Total Stockholder Equity 245.2m)
RoCE = 4.10% (EBIT 46.3m / Capital Employed (Equity 245.2m + L.T.Debt 883.6m))
RoIC = 3.38% (NOPAT 36.6m / Invested Capital 1.08b)
WACC = 6.18% (E(997.2m)/V(1.89b) * Re(10.30%) + D(896.9m)/V(1.89b) * Rd(2.02%) * (1-Tc(0.21)))
Discount Rate = 10.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.28%
[DCF] Terminal Value 79.85% ; FCFF base≈94.1m ; Y1≈61.8m ; Y5≈28.3m
[DCF] Fair Price = N/A (negative equity: EV 849.9m - Net Debt 850.2m = -309k; debt exceeds intrinsic value)
EPS Correlation: -8.69 | EPS CAGR: 7.31% | SUE: 0.39 | # QB: 0
Revenue Correlation: -4.80 | Revenue CAGR: -3.26% | SUE: 1.92 | # QB: 1
EPS next Quarter (2026-06-30): EPS=-0.05 | Chg7d=+0.022 | Chg30d=-0.026 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-09-30): EPS=0.81 | Chg7d=+0.000 | Chg30d=+0.094 | Revisions Net=+1 | Growth EPS=+268.4% | Growth Revenue=-1.1%
EPS next Year (2027-09-30): EPS=1.02 | Chg7d=+0.000 | Chg30d=+0.028 | Revisions Net=+3 | Growth EPS=+25.9% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)
P/S = 0.6585
P/B = 3.4551
P/EG = 0.1192
Revenue TTM = 1.33b USD
EBIT TTM = 46.3m USD
EBITDA TTM = 149.1m USD
Long Term Debt = 883.6m USD (from longTermDebt, last quarter)
Short Term Debt = 6.90m USD (from shortTermDebt, last quarter)
Debt = 896.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 850.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.85b USD (997.2m + Debt 896.9m - CCE 46.7m)
Interest Coverage Ratio = 0.66 (Ebit TTM 46.3m / Interest Expense TTM 69.7m)
EV/FCF = 19.63x (Enterprise Value 1.85b / FCF TTM 94.1m)
FCF Yield = 5.09% (FCF TTM 94.1m / Enterprise Value 1.85b)
FCF Margin = 7.06% (FCF TTM 94.1m / Revenue TTM 1.33b)
Net Margin = -2.82% (Net Income TTM -37.6m / Revenue TTM 1.33b)
Gross Margin = 16.48% ((Revenue TTM 1.33b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 15.96% (prev 16.88%)
Tobins Q-Ratio = 1.21 (Enterprise Value 1.85b / Total Assets 1.53b)
Interest Expense / Debt = 2.02% (Interest Expense 18.1m / Debt 896.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 36.6m (EBIT 46.3m * (1 - 21.00%))
Current Ratio = 2.59 (Total Current Assets 632.2m / Total Current Liabilities 243.7m)
Debt / Equity = 3.44 (Debt 896.9m / totalStockholderEquity, last quarter 260.5m)
Debt / EBITDA = 5.70 (Net Debt 850.2m / EBITDA 149.1m)
Debt / FCF = 9.04 (Net Debt 850.2m / FCF TTM 94.1m)
Total Stockholder Equity = 245.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.32% (Net Income -37.6m / Total Assets 1.53b)
RoE = -15.33% (Net Income TTM -37.6m / Total Stockholder Equity 245.2m)
RoCE = 4.10% (EBIT 46.3m / Capital Employed (Equity 245.2m + L.T.Debt 883.6m))
RoIC = 3.38% (NOPAT 36.6m / Invested Capital 1.08b)
WACC = 6.18% (E(997.2m)/V(1.89b) * Re(10.30%) + D(896.9m)/V(1.89b) * Rd(2.02%) * (1-Tc(0.21)))
Discount Rate = 10.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.28%
[DCF] Terminal Value 79.85% ; FCFF base≈94.1m ; Y1≈61.8m ; Y5≈28.3m
[DCF] Fair Price = N/A (negative equity: EV 849.9m - Net Debt 850.2m = -309k; debt exceeds intrinsic value)
EPS Correlation: -8.69 | EPS CAGR: 7.31% | SUE: 0.39 | # QB: 0
Revenue Correlation: -4.80 | Revenue CAGR: -3.26% | SUE: 1.92 | # QB: 1
EPS next Quarter (2026-06-30): EPS=-0.05 | Chg7d=+0.022 | Chg30d=-0.026 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-09-30): EPS=0.81 | Chg7d=+0.000 | Chg30d=+0.094 | Revisions Net=+1 | Growth EPS=+268.4% | Growth Revenue=-1.1%
EPS next Year (2027-09-30): EPS=1.02 | Chg7d=+0.000 | Chg30d=+0.028 | Revisions Net=+3 | Growth EPS=+25.9% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)